Clinical Trials Browser

Phase NA × gp100 Melanoma Antigen × Dermatologic × Clear all

NCT00006243 2013-01-25

Vaccine Therapy and Sargramostim in Treating Patients With Stage IV Malignant Melanoma

Phase NA Completed

Melanoma